Women’s health marketing has an important challenge: patients cannot ask about a health connection they do not know exists. A new Bausch + Lomb survey offers a striking example. Only 14% of surveyed perimenopausal, menopausal, and postmenopausal women recognized dry eye as a potential menopause-related symptom, compared with 79% who recognized hot flashes. That gap is more than an interesting statistic. For pharma marketers, it reveals where better disease education could help women connect symptoms they already experience with health information they may not yet know.
Table of Contents
- Why the menopause awareness gap matters to pharma marketers
- Finding hidden knowledge gaps in women’s health
- Turning disease education into patient understanding
- Measuring women’s health awareness, not just campaign reach
- Conclusion
- FAQs
Why the Menopause Awareness Gap Matters to Pharma Marketers
According to Bausch + Lomb’s 2026 (Peri)Menopause Survey, 78% of respondents were surprised to learn about the association between dry eye and perimenopause or menopause. Among women experiencing dry eye during these life stages, 80% said the symptom came as a surprise.
Those numbers expose an important distinction between symptom awareness and health understanding. A woman may know that her eyes feel dry, irritated, or uncomfortable. However, she may never connect those symptoms with the hormonal changes occurring during menopause.
That missing connection matters. The survey found that women experiencing dry eye reported problems with reading, screen use, driving, and productivity. In other words, the symptom can affect everyday life even when its potential cause remains poorly understood.
For teams marketing women’s health products and services, this is where disease education becomes especially valuable. Instead of simply reminding people that a condition exists, marketers can help consumers connect experiences they already recognize with health information they may not know.
That approach can make educational content more relevant. It can also give patients better questions to bring to healthcare professionals. Most importantly, it puts patient understanding ahead of simply delivering another marketing message.
Finding Hidden Knowledge Gaps in Women’s Health
The dry eye example raises a broader question: what other health connections are consumers experiencing without understanding?
Pharma marketers often begin with disease prevalence, diagnosis rates, treatment patterns, and audience demographics. Those measures remain important. However, marketers should also examine the distance between what patients experience and what they understand.
Social listening can help reveal that distance. Search behavior, patient forums, surveys, HCP interviews, and community conversations can show how people describe symptoms before they have clinical language for them.
For example, consumers may search for an everyday problem rather than a disease name. They might ask why a symptom suddenly appeared, whether it is normal at a certain age, or whether two seemingly unrelated changes could be connected.
Those questions can provide valuable insights for women’s health campaigns and patient education strategies. Instead of forcing consumers into pharmaceutical terminology, educational content can begin with the language people already use.
Pharma Marketing Network has previously explored how the FemTech era is changing women’s health pharma marketing. Consumers increasingly expect open, useful conversations about menopause, fertility, hormonal health, and other topics that were once discussed less directly.
Therefore, marketers have an opportunity to listen for what women do not yet know, not just what they already understand. Those gaps can become starting points for more useful patient education.
Turning Disease Education Into Patient Understanding
A knowledge gap alone does not justify a campaign. The information must also be useful, accurate, and connected to a meaningful next step.
Consider the menopause and dry eye example. The strongest educational message is not simply, “Menopause can cause dry eye.” Instead, useful content explains why the connection may matter, what symptoms consumers could notice, and when they may want to speak with an eye care professional.
That progression moves a consumer from recognition to understanding and then toward appropriate action.
Bausch + Lomb notes that hormonal changes during perimenopause and menopause can affect tear production, tear quality, and tear evaporation. As a result, women may experience burning, irritation, fluctuating vision, or discomfort. That clinical connection gives marketers a foundation for education without turning every message into a product pitch.
The same approach can work across many areas of women’s health. Brands can identify overlooked symptom connections, explain them simply, and help consumers prepare for more informed conversations with healthcare professionals.
Moreover, educational campaigns should connect patient and HCP communications. A consumer campaign that raises a new question works better when clinicians are prepared to discuss the same issue.
Disease education should not manufacture anxiety. Instead, it should reduce uncertainty and give people clearer paths toward credible health information and professional care.
Measuring Women’s Health Awareness, Not Just Campaign Reach
Traditional campaign metrics can tell marketers whether people saw an ad, clicked a page, or watched a video. However, they do not necessarily show whether the audience learned anything.
For awareness-gap campaigns, that distinction is critical.
Women’s health marketers can establish a baseline before launch. What percentage of the target audience recognizes a symptom? How many understand its potential connection with a condition or life stage? How confident are they about what to do next?
Then, marketers can measure changes in those numbers over time. That approach provides a clearer picture of whether disease education is actually closing the knowledge gap.
Search behavior can offer another signal. For instance, a successful education effort may produce more specific searches as consumers move from vague symptom questions toward better-informed health queries.
Engagement quality also matters. Time spent with educational resources, content completion rates, HCP discussion guides, and visits to credible clinical information may tell marketers more than raw impressions.
This approach fits a broader shift toward sustained disease awareness strategies rather than short bursts of attention. The goal is not merely to generate visibility. Instead, it is to leave consumers knowing something useful that they did not know before.
That may be one of the most meaningful measures of healthcare marketing performance.
Conclusion
The 14% figure from Bausch + Lomb is compelling because it reveals more than low awareness. It shows the distance that can exist between experiencing a health problem and understanding what may be behind it.
For pharma marketers focused on women’s health, that distance represents an opportunity for better education. Marketers can identify overlooked connections through research, patient language, search behavior, and HCP insights. Then, they can turn those findings into simple, credible content that helps consumers recognize symptoms and have better healthcare conversations.
The best disease education does not just tell an audience that a condition exists. It creates the moment when someone thinks, “I didn’t know those things could be connected.”
For pharma marketers, finding those moments may be where some of the most valuable women’s health campaigns begin.
FAQs
Why is the 14% menopause statistic important for pharma marketers?
It demonstrates a significant awareness gap. Consumers may experience a symptom without understanding its possible relationship to menopause, creating an opportunity for responsible disease education.
How can marketers find similar women’s health knowledge gaps?
Teams can combine surveys, search data, social listening, patient communities, HCP interviews, and qualitative research. The goal is to identify differences between what consumers experience and what they understand.
What makes disease education effective?
Strong disease education starts with recognizable patient experiences, explains health connections in simple language, and offers a credible next step. It should educate rather than create unnecessary fear.
Should women’s health campaigns target HCPs as well as consumers?
Yes. Patient education can generate new questions, so aligned HCP communication can help clinicians address those questions with accurate information and appropriate guidance.
How should marketers measure an awareness campaign?
Beyond impressions and clicks, teams can measure changes in symptom recognition, understanding, search behavior, educational engagement, and confidence about speaking with a healthcare professional.
This content is not medical advice. For any health issues, always consult a healthcare professional. In an emergency, call 911 or your local emergency services.
